Gujarat Terce Laboratories P/E Ratio
Current P/E Ratio
11.93
Low Valuation
Low - May indicate good value opportunity
Gujarat Terce Laboratories P/E ratio. Gujarat Terce Laboratories (GUJTERC) P/E ratio is 11.93 (Low), EPS (TTM) ₹2.92, current price ₹34.83 on BSE — Low - May indicate good value opportunity. Examine Gujarat Terce Laboratories quarterly earnings for recent quarterly revenue, profit and EPS trends.
Current Valuation Metrics
P/E Ratio
11.93
Current Price
₹34.83
EPS (TTM)
₹2.92
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
56.2
Sector Median
32.5
Sector Rank
#11 of 200
Sector Percentile
5.5%
Earnings Breakdown (TTM)
TTM EPS
₹2.15
Sept 2021
₹0.61
Jun 2021
₹2.16
GUJTERC P/E Ratio — Valuation Signal & Historical Context
Gujarat Terce Laboratories P/E 11.93 — signal: Undervalued. For live price, revenue and the complete fundamental profile, see Gujarat Terce Laboratories stock price NSE.
- Stock appears undervalued with PE of 11.93, suggesting potential buying opportunity
- Trading at discount to sector average PE of 56.2
GUJTERC vs Healthcare Peers — P/E Ratio Comparison
Gujarat Terce Laboratories P/E 11.93 vs Healthcare average 56.2, median 32.5 — range 2.04–740.29.
Sector Average
56.2
Sector Median
32.5
Lowest P/E
2.04
Highest P/E
740.29
Companies
200
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| GKB Ophthalmics | GKB | 5.88 | ₹32 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |